Rosacea may increase the risk of developing Parkinson’s disease (PD), according to an analysis of 5.4 million adults in a Danish database.
The database included 22,387 PD patients (43.8% women; mean age at diagnosis 75.9 years) and 68,053 people with rosacea (67.2% women; mean age 42.2 years). PD incidence was 3.54 and 7.62 per 10,000 person-years in the reference and rosacea groups respectively. The adjusted risk of PD was 71% higher in patients with rosacea. PD risk was doubled in patients with ocular rosacea (incidence rate ratio [IRR] 2.03). Tetracyclines, used to treat rosacea, slightly, but significantly, reduced PD risk (IRR 0.98 for each filled prescription).
Register now for access
Thank you for visiting Independent Nurse and reading some of our premium content. To read more, please register today.
Register
Already have an account? Sign in here